Esmon, 1983 - Google Patents

Protein C: biochemistry, physiology and clinical implications

Esmon, 1983

Document ID: 6464529240833719417
Author: Esmon C
Publication year: 1983
Publication venue: Blood

External Links

Cited by

Snippet

P ROTEIN-C is a vitamin-K-dependent plasma zymogen.'After activation, activated protein-C differs from the vitamin-K-dependent plasma clotting factors in that it potently inhibits coagulation5 by inactivating factors V6'7 and VIII, 7'8 and it facilitates fibrinolysis in …

Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

229960000856 Protein C 0 title abstract description 73

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

Similar Documents

Publication	Publication Date	Title
Esmon	1983	Protein C: biochemistry, physiology and clinical implications
Lawson et al.	2004	Challenges for providing effective hemostasis in surgery and trauma
Heeb et al.	1989	Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation
Cruz et al.	2019	DNA‐bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma
Bauer et al.	1987	The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation
Rodeghiero et al.	1984	Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia
US7879803B2 (en)	2011-02-01	Methods of treatment involving the protease for activating clotting factor VII
Pabinger-Fasching et al.	1983	Protein C deficiency in two Austrian families
Marciniak et al.	1989	Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant
Sala et al.	1984	A functional assay of protein C in human plasma
EP0642352B1 (en)	1999-01-20	TRUNCATED TISSUE FACTOR AND FVIIa OR FVII ACTIVATOR FOR BLOOD COAGULATION
Budzynski et al.	1984	Fibrinogenolytic afibrinogenemia after envenomation by western diamondback rattlesnake (Crotalus atrox)
JPH07501217A (en)	1995-02-09	How to diagnose blood clotting disorders
Braunstein et al.	1981	Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.
Holmberg et al.	1982	Studies of the blood plasminogen activator induced by 1-desamino-8-D-arginine vasopressin with observations in von Willebrand's disease
Hedner et al.	1978	Inhibition of activated haceman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor)
Bangalore et al.	1994	High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells
Köhler et al.	1990	Comparison of different prothrombin complex concentrates-in vitro and in vivo studies
De Fouw et al.	1988	The influence of thrombin and platelets on fibrin clot lysis rates in vitro: a study using a clot lysis system consisting of purified human proteins
Jeljaszewicz et al.	1965	Intravascular Coagulation and Fibrinolysis by Stapliylocoagiilase. Comparison with Thrombin
Sala et al.	1987	Dysfunctional activated protein C (PC Cadiz) in a patient with thrombotic disease
Bennett	1984	Blood coagulation and coagulation tests
van de Waart et al.	1987	A functional test for protein S activity in plasma
Walker	1990	Protein C deficiency in liver disease
Giansily-Blaizot et al.	2003	Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas